T. David Bourne, MD
Dr. David Bourne joined Arkana in 2016. He received his medical degree from the University of Texas Medical School in Houston followed by pathology residency and fellowship training at the University of Virginia. He completed his renal pathology fellowship at Arkana Laboratories. Dr. Bourne brings a unique skillset and perspective to Arkana as he has training and proficiency in many of the esoteric fields of pathology such as neuropathology, renal pathology, transplant pathology, and ophthalmic pathology. Beyond his diagnostic skill and multiple specializations, Dr. Bourne is best known around Arkana for his consistent excellence in everything he does, as well as the humble, kind, and compassionate way he works with his colleagues and clinicians. He also contributes to our Social Media team where he produces “Teaching Points” and “KDIGO Connections” visual abstracts.
Dr. Bourne is a member of the United States and Canadian Academy of Pathologists, the College of American Pathologists, the American Society for Clinical Pathologists, and the American Association of Neuropathologists.
Education & Stats
Our fellowship-trained pathologists have decades of experience interpreting biopsies.
|Joined the Arkana Team||2016|
|Doctor of Medicine||University of Texas Medical School|
|Pathology Residency||University of Virginia|
|Board Certification||American Board of Pathology|
|Neuropathology Fellowship||University of Virginia|
|Renal Pathology Fellowship||Arkana Laboratories|
Publications by T. David Bourne, M.D.
A multi-center retrospective cohort study defines the spectrum of kidney… A multi-center retrospective cohort study defines…
Kidney failure is common in patients with Coronavirus Disease-19 (COVID-19), resulting in increased morbidity and…
Kidney failure is common in patients with Coronavirus Disease-19 (COVID-19), resulting in increased morbidity and mortality.
Coronavirus disease 2019 (COVID-19) is the official name given by the World Health Organization to the disease caused…
Coronavirus disease 2019 (COVID-19) is the official name given by the World Health Organization to the disease caused by the novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Dexamethasone administration during definitive radiation and temozolomide renders… Dexamethasone administration during definitive…
Dexamethasone (DXM) is commonly used in the management of cerebral edema in patients diagnosed with glioblastoma…
Dexamethasone (DXM) is commonly used in the management of cerebral edema in patients diagnosed with glioblastoma multiforme (GBM).
Cerebral amyloid angiopathy-related inflammation: A potentially reversible cause… Cerebral amyloid angiopathy-related inflammation:…
Cerebral amyloid angiopathy with inflammation (CAA-I) is a less well-recognized clinically and radiologically distinct…
Cerebral amyloid angiopathy with inflammation (CAA-I) is a less well-recognized clinically and radiologically distinct subtype of CAA.